Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)
February 4, 2022 01:32 PM ESTUpdated 01:44 PM
Pharma

With thou­sands of jobs on the chop­ping block, 'noth­ing's off the table' at Sanofi. What's stay­ing and what's go­ing?

Nicole DeFeudis

Editor

A day af­ter un­veil­ing an en­tire­ly new look for Sanofi — com­plete with a new lo­go and cor­po­rate brand — CEO Paul Hud­son has reaf­firmed his …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Up­dat­ed: Bio­gen makes cuts across its re­search unit, shift­ing fo­cus to ‘ex­ter­nal op­por­tu­ni­ties’

Chi­nese start­up be­gins first tri­al of in vi­vo CRISPR ther­a­py for blood dis­ease

RFK Jr. says he’ll di­vest in­ter­ests in CRISPR Ther­a­peu­tics if con­firmed for HHS chief

'No mir­a­cles': What Re­gen­eron's George Yan­copou­los re­al­ly thinks of AI

GLP-1s can cut the risk of Alzheimer’s. What does that mean for No­vo Nordisk?

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times